ArticleClinical diabetes : a publication of the American Diabetes Association2022

Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease.

Andrew A Swanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.